Research & Clinical Summary

Dysregulated B cell development and signaling leading to immunodeficiency, autoimmunity or lymphoid malignancies, and the development of gene therapy for primary immune deficiency diseases.

Interests: Cell and Gene Therapy, Genetic Disease, Genomics, Infectious Disease, Inflammation

Publications

More publications associated with this author on PubMed

The following publications were retrieved from PubMed:

596Rawlings, David J.

More publications associated with this author on PubMed